Arch Biopartners Announces Listing on OTCQB Exchange
16 mai 2018 06h00 HE | Arch Biopartners
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners, Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCQB:ACHFF) a portfolio-based biotechnology company, announced that the Company’s common...
logo.png
Arch Biopartners Arranges Convertible Note Financing
08 févr. 2018 07h30 HE | Arch Biopartners
TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture:ARCH) (OTCBB:ACHFF), announced it has arranged a non-brokered, unsecured convertible note...
logo.png
Arch Biopartners Announces Completion of GMP Manufacturing of AB569 and Start Date of Phase I Trial
06 déc. 2017 10h08 HE | Arch Biopartners
TORONTO, Dec. 06, 2017 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB:ACHFF) today announced that the good manufacturing practice (GMP) production...